Related Experiment Video
Updated: Jan 14, 2026

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
Clinical progress note: Antibiotic duration for common infections in hospitalized adults
William Aaron Manning1,2, Matthew Miller3,4
1Division of Hospital Medicine, University of Colorado School of Medicine, Aurora, Colorado, USA.
Abstract:
The evidence base supporting the effectiveness of shorter antibiotic courses for a variety of common infections has grown substantially, yet many implementation barriers remain. We examine recent data evaluating shorter antibiotic courses for bacteremia, community-acquired pneumonia, ventilator-associated pneumonia, and complicated urinary tract infections/pyelonephritis.
Insights
Shorter antibiotic courses are effective for common infections like bacteremia and pneumonia. However, challenges in implementing these shorter treatment durations persist, hindering widespread adoption.
Area of Science:
- Infectious Diseases
- Clinical Pharmacy
- Antimicrobial Stewardship
Background:
- Growing evidence supports shorter antibiotic durations for common infections.
- Implementation barriers hinder the adoption of evidence-based shorter antibiotic courses.
- Optimizing antibiotic therapy is crucial for combating antimicrobial resistance.
Purpose of the Study:
- To review recent data on the effectiveness of shorter antibiotic courses.
- To examine the application of shorter antibiotic regimens for specific infections.
- To identify persistent barriers to the implementation of shorter antibiotic courses.
Main Methods:
- Review of recent clinical data and evidence.
- Analysis of treatment outcomes for specific infections.
- Evaluation of implementation challenges in clinical practice.
Main Results:
- Evidence supports the efficacy of shorter antibiotic courses for bacteremia.
- Shorter regimens are effective for community-acquired pneumonia and ventilator-associated pneumonia.
- Efficacy of shorter courses is also demonstrated for complicated urinary tract infections/pyelonephritis.
Conclusions:
- Shorter antibiotic courses are effective for multiple common infections.
- Implementation barriers remain a significant challenge to widespread adoption.
- Further strategies are needed to overcome barriers and promote evidence-based prescribing.
More Related Videos
07:44Time-Lapse Epifluorescence Microscopy Imaging of Pseudomonas aeruginosa and Staphylococcus aureus Heterogeneous Phenotypes
Published on: February 14, 2025
09:17A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
Published on: January 2, 2017
Related Concept Videos
Acute Pyelonephritis II: Diagnostic Studies and Management
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Antimicrobial Effectiveness
Urine Studies II: Urine Culture and Sensitivity Test
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...